Schizophrenia: all 3,539 studies
Page 26 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Schizophrenia and Physical ExerciseCompletedNCT01595698Not applicable
- Melatonin for Prevention of Metabolic Side Effects of OlanzapineCompletedNCT01593774Phase 2
- A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic DrugTerminatedNCT01592201Phase 4
- A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With SchizophreniaCompletedNCT01592110Phase 1
- Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS)CompletedNCT01590784
- Prevalence of and Factors Associated With Metabolic Syndrome in SchizophreniaCompletedNCT01587521
- CHANGE -it is About LifeCompletedNCT01585493Phase 3
- Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot StudyWithdrawnNCT01584466Not applicable
- Social Cognitive Training for Psychosis: Treatment DevelopmentCompletedNCT01579422Phase 1
- Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With SchizophreniaTerminatedNCT01576640Phase 4
- Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal WomenCompletedNCT01573637Phase 3
- Mediators and Moderators of Treatment Outcome in Recent-Onset PsychosisCompletedNCT01570972Not applicable
- 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)TerminatedNCT01568229Phase 2
- 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsTerminatedNCT01568216Phase 2
- First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable SchizophreniaTerminatedNCT01568203Phase 1
- Alleviating the Metabolic Side Effects of Antipsychotic MedicationsWithdrawnNCT01567124Phase 4
- Glucose as a Mediator of Self-control Performances in Patients With SchizophreniaStatus unknownNCT01563016Not applicable
- Brain Imaging, Cognitive Enhancement and Early SchizophreniaCompletedNCT01561859Not applicable
- Minocycline Augmentation in SchizophreniaStatus unknownNCT01561742Not applicable
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With SchizophreniaCompletedNCT01559272Phase 1
- Intracellular Tight Junction Permeability in Schizophrenia: Focus on ZonulinCompletedNCT01558570
- Gluten Free Diet in People With Schizophrenia: A Pilot StudyCompletedNCT01558557Not applicable
- Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagenCompletedNCT01555814Not applicable
- Treatment Development Targeting Severe and Persistent Negative SymptomsCompletedNCT01550666Not applicable
- Add-on Sodium Nitroprusside to Treatment as Usual in SchizophreniaCompletedNCT01548612Phase 2
- Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic PatientsCompletedNCT01547026Not applicable
- Cognitive Remediation in Early Phase PsychosisStatus unknownNCT01546467Not applicable
- Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With SchizophreniaActive, not recruitingNCT01545999Not applicable
- A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With SchizophreniaCompletedNCT01545310Phase 1
- Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of SchizophreniaCompletedNCT01544608
- Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in HungaryCompletedNCT01534936
- A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute SchizophreniaCompletedNCT01527305Phase 4
- Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian HospitalCompletedNCT01526395Not applicable
- Ginkgo Biloba Extract for SchizophreniaCompletedNCT01524380Not applicable
- Effects of rTMS on Cigarette Smoking and Cognition in SchizophreniaCompletedNCT01523730Not applicable
- Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric DisordersCompletedNCT01519557Early Phase 1
- A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With SchizophreniaCompletedNCT01518894Phase 1
- Pharmacological Approach to Improve the Outcome of Social Cognition TrainingCompletedNCT01517360Phase 1
- Prevalence of Dissociative Disorders in ChildrenCompletedNCT01512641Not applicable
- Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal HallucinationsCompletedNCT01512290Not applicable
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy VolunteersCompletedNCT01511510Phase 1
- Cognitive Behavioral Therapy for Patients With an Early PsychosisCompletedNCT01511406Phase 2
- Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of SchizophreniaCompletedNCT01506765Phase 1
- Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in SchizophreniaCompletedNCT01503359Phase 2
- Evaluation of Generalization Paradigm Patterns Among Different Psychiatric DisordersStatus unknownNCT01501812
- Pregablin for Anxiety-comorbidity in Patients With SchizophreniaCompletedNCT01496690Phase 4
- Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307)CompletedNCT01495741
- The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working MemoryCompletedNCT01494623Not applicable
- A Study of ALKS 9072 in Subjects With Chronic Stable SchizophreniaCompletedNCT01493726Phase 1
- The Study of Minocycline for Negative and Cognitive Symptoms in SchizophreniaCompletedNCT01493622Phase 4
- Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of SchizophreniaCompletedNCT01491412
- A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaStatus unknownNCT01490567Phase 4
- Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With SchizophreniaCompletedNCT01488929Phase 2
- A Long-Term Safety Study of Pomaglumetad Methionil in SchizophreniaTerminatedNCT01487083Phase 3
- Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?CompletedNCT01481883Phase 4
- Mitochondria and Schizophrenia: Effects of Antipsychotic DrugsCompletedNCT01479413
- Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective StudyCompletedNCT01479400
- Prevalence of Metabolic Syndrome in Patients With Schizophrenia in KoreaStatus unknownNCT01477918
- N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in SchizophreniaStatus unknownNCT01474395Phase 2
- Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential ComponentCompletedNCT01466439Phase 2
- Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With SchizophreniaTerminatedNCT01465074Not applicable
- High Dose D-Serine as Adjuvant Treatment for Recent Onset SchizophreniaStatus unknownNCT01459029Phase 2
- Optimisation of Antipsychotic Drug Use in Older PeopleTerminatedNCT01454453Phase 4
- Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode SchizophreniaCompletedNCT01451736Phase 4
- POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaCompletedNCT01450514Phase 2
- Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone PalmitateCompletedNCT01448720Phase 3
- Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia PatientsWithdrawnNCT01448499Not applicable
- General Practice Research Database Seroquel XR Safety StudyCompletedNCT01447082
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- Study on Psychoeducation Enhancing Results of Adherence in SchizophreniaCompletedNCT01433094Not applicable
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With SchizophreniaCompletedNCT01431092Phase 4
- A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy AdultsCompletedNCT01429740Phase 1
- rTMS-induced Cumulative Pattern of sBDNF in Chronic SchizophreniaCompletedNCT01427088Not applicable
- Brain Circuits in Schizophrenia and SmokingCompletedNCT01425684
- Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease StatesCompletedNCT01425671
- Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed AdultsCompletedNCT01422902Phase 2
- Decision Aid to Facilitate Shared Decision Making During Treatment in SchizophreniaTerminatedNCT01420575Not applicable
- Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic MedicationsCompletedNCT01409590Not applicable
- Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and FluvoxamineCompletedNCT01401491Phase 4
- Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia PatientsCompletedNCT01399450Phase 4
- Brain Functions Underlying Visuospatial Attention Deficits in SchizophreniaCompletedNCT01399437
- F-18 Altanserin PET Study of Patients Receiving ClozapineStatus unknownNCT01398189Not applicable
- Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI)CompletedNCT01394757Not applicable
- A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of SchizophreniaCompletedNCT01394601
- Oxytocin Treatment of Social Cognitive and Functional Deficits in SchizophreniaCompletedNCT01394471Phase 1
- IBIS: Italian Burden of Illness on Schizophrenia & Bipolar DisorderCompletedNCT01392482
- Artemisinin With Risperidone for First-Episode and Drug-Naive SchizophreniaCompletedNCT01391403Phase 3
- DAAOI-1 Treatment for Treatment-resistant SchizophreniaCompletedNCT01390376Phase 2
- A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01389908Not applicable
- Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in SchizophreniaCompletedNCT01386918Not applicable
- Neurophysiological Studies in Schizophrenia and Psychiatric DisordersCompletedNCT01384604
- Clinical Risk State for Bipolar Disorder in AdolescentsStatus unknownNCT01383915
- First Time in Human Study (FTIH) With Positron Emission Tomography (PET)CompletedNCT01381419Phase 1
- Evaluation of Dorsal Visual Stream in Patients With SchizophreniaCompletedNCT01378403
- Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With SchizophreniaCompletedNCT01378078Not applicable
- The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription BehavioursCompletedNCT01377896
- Group Cognitive-behavioral Intervention for Social Anxiety in SchizophreniaCompletedNCT01376596Phase 1/2
- FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in SpainCompletedNCT01376492
- Effects of Cariprazine on Cardiac Repolarization in Patients With SchizophreniaCompletedNCT01376076Phase 1